1. Introduction to special focus section on prostate cancer imaging

   • Adam T. Froemming
   • Alvin C. Silva

   Invited article 03 May 2016 Pages: 797 - 797

2. Engaging and educating patients in prostate imaging via social media

   • Baris Turkbey
   • Andrew B. Rosenkrantz

   Commentary 30 April 2016 Pages: 798 - 798

3. Is it time for prostate MRI certification?

   • Antonio C. Westphalen
   • Sadhna Verma
   • Ronald J. Zagoria

   Invited article 23 April 2016 Pages: 799 - 800

4. Why we need a vendor neutral specification for delineating prostate cancer with mpMRI

   • Daniel J. A. Margolis
   • Antonio C. Westphalen
   • Masoom A. Haider

   OriginalPaper 23 April 2016 Pages: 801 - 802

5. How and why a generation of radiologists must be trained to accurately interpret prostate mpMRI

   • Rajan T. Gupta
   • Benjamin Spilseth
   • Adam T. Froemming

   Invited Commentary 02 May 2016 Pages: 803 - 804

6. A urologist’s perspective on prostate cancer imaging: past, present, and future

   • Arvin K. George
   • Baris Turkbey
   • Peter A. Pinto

   OriginalPaper 02 May 2016 Pages: 805 - 816

   

7. Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation

   • Olga Starobinets
   • Natalie Korn
   • Antonio C. Westphalen

   OriginalPaper 21 December 2015 Pages: 817 - 830

   

8. Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer

   • Rajan T. Gupta
   • Benjamin Spilseth
   • Jinxing Yu

   OriginalPaper 22 December 2015 Pages: 831 - 843

   

9. DCE MRI of prostate cancer

   • Rose M. Berman
   • Anna M. Brown
   • Baris Turkbey

   OriginalPaper 02 January 2016 Pages: 844 - 853

   

10. The expanding landscape of diffusion-weighted MRI in prostate cancer

    • Andreas G. Wibmer
    • Evis Sala
    • Hebert Alberto Vargas

    OriginalPaper 27 January 2016 Pages: 854 - 861

    

11. Prostate cancer post-treatment follow-up and recurrence evaluation

    • Eric J. May
    • Lyndsay D. Viers
    • Adam T. Froemming

    OriginalPaper 06 January 2016 Pages: 862 - 876

    

12. Targeted prostate biopsy and MR-guided therapy for prostate cancer

    • David A. Woodrum
    • Akira Kawashima
    • Lance A. Mynderse

    Invited Article 24 February 2016 Pages: 877 - 888

    

13. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer

    • Hossein Jadvar

    OriginalPaper 06 January 2016 Pages: 889 - 898

    

14. A practical primer on PI-RADS version 2: a pictorial essay

    • Gary Lloyd Horn Jr.
    • Peter Florin Hahn
    • Mukesh Harisinghani

    Pictorial Essay 16 March 2016 Pages: 899 - 906

    

15. Commentary regarding the inter-reader reproducibility of PI-RADS version 2

    • Andrew B. Rosenkrantz
    • Daniel J. Margolis

    Commentary 02 May 2016 Pages: 907 - 909

16. Benign causes of diffusion restriction foci in the peripheral zone of the prostate: diagnosis and differential diagnosis

    • Nirjhor M. Bhowmik
    • Jinxing Yu
    • Mary A. Turner

    Pictorial Essay Open access 12 April 2016 Pages: 910 - 918

    

17. Zoomed echo-planar diffusion tensor imaging for MR tractography of the prostate gland neurovascular bundle without an endorectal coil: a feasibility study

    • Justin M. Ream
    • Christopher Glielmi
    • Andrew B. Rosenkrantz

    OriginalPaper 02 January 2016 Pages: 919 - 925

    

18. Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?

    • R. Faletti
    • G. Battisti
    • P. Fonio

    OriginalPaper 07 January 2016 Pages: 926 - 933

    

19. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection

    • Sadhna Verma
    • Saradwata Sarkar
    • Krishnanath Gaitonde

    OriginalPaper 09 January 2016 Pages: 934 - 945

    

20. Restriction spectrum imaging improves MRI-based prostate cancer detection

    • Kevin C. McCammack
    • Natalie M. Schenker-Ahmed
    • David S. Karow

    OriginalPaper 24 February 2016 Pages: 946 - 953

    

21. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer

    • Ely R. Felker
    • Stephanie A. Lee-Felker
    • Steven S. Raman

    OriginalPaper 27 April 2016 Pages: 954 - 962

    

22. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas

    • Eric C. Ehman
    • Spencer C. Behr
    • Thomas A. Hope

    OriginalPaper 02 January 2016 Pages: 963 - 969

    

23. Incidence and clinical sequelae of portal and hepatic venous thrombosis following percutaneous cryoablation of liver tumors

    • Nisha I. Sainani
    • Stuart G. Silverman
    • Servet Tatli

    OriginalPaper 07 January 2016 Pages: 970 - 977

    

24. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings

    • Yi-Jun Zhao
    • Wei-xia Chen
    • Li-rong Zheng

    OriginalPaper 14 January 2016 Pages: 978 - 989

    

25. Optimal visualization of focal nodular hyperplasia: quantitative and qualitative evaluation of single and multiphasic arterial phase acquisition at 1.5 T MR imaging

    • Caroline Rousseau
    • Maxime Ronot
    • Marc Zins

    OriginalPaper 07 January 2016 Pages: 990 - 1000

    

26. The “gallbladder pearl necklace” sign

    • Pratik Mukherjee
    • Ashish Chawla
    • Raymond Chung

    Classics in Abdominal Imaging 08 January 2016 Pages: 1001 - 1002

    

27. The “Sausage” pancreas

    • Qiong Han
    • Halemane Ganesh
    • David J. DiSantis

    Classics in Abdominal Imaging 19 January 2016 Pages: 1003 - 1003

    

28. Inverted V sign

    • Eleni M. Maroudas
    • Andres R. Ayoob
    • David J. DiSantis

    Classics in Abdominal Imaging 20 January 2016 Pages: 1004 - 1004